On September 14, 2020 Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI); (OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, reported Jesse Ledger, Nuvo’s President & Chief Executive Officer and Kelly Demerino, Nuvo’s Interim Chief Financial Officer will present live at LifeSciencesInvestorForum.com on September 17th (Press release, Nuvo Pharmaceuticals, SEP 14, 2020, View Source [SID1234565133]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

DATE:

Thursday, September 17, 2020

TIME:

1:30 p.m. ET

LINK:

https://bit.ly/30GjErk

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.